Bill Sponsors: NY S08991 | 2023-2024 | General Assembly

Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

Spectrum: Bipartisan Bill

Status: (Introduced) 2024-06-03 - PRINT NUMBER 8991A [S08991 Detail]

Text: Latest bill text (Amended) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Senator Peter Harckham [D]PrimarySponsored BillsSD-040FollowTheMoneyBallotpediaVoteSmart
Senator Jacob Ashby [R]CosponsorSponsored BillsSD-043FollowTheMoneyBallotpediaVoteSmart
Senator Jeremy Cooney [D]CosponsorSponsored BillsSD-056FollowTheMoneyBallotpediaVoteSmart
Senator Patrick Gallivan [R]CosponsorSponsored BillsSD-060FollowTheMoneyBallotpediaVoteSmart
Senator Peter Oberacker [R]CosponsorSponsored BillsSD-051FollowTheMoneyBallotpediaVoteSmart

Social Comments on NY S08991

feedback